A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma

This study aimed to develop a reliable immune signature based on B-cell proportion to predict the prognosis and benefit of immunotherapy in LUAD. The proportion of immune cells in the TCGA-LUAD dataset was estimated using MCP-counter.